BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28203756)

  • 21. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.
    Monaco G; Decrock E; Akl H; Ponsaerts R; Vervliet T; Luyten T; De Maeyer M; Missiaen L; Distelhorst CW; De Smedt H; Parys JB; Leybaert L; Bultynck G
    Cell Death Differ; 2012 Feb; 19(2):295-309. PubMed ID: 21818117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the BH3 domain mediated protein-protein interaction of Bcl-xL through virtual screening.
    Mukherjee P; Desai P; Zhou YD; Avery M
    J Chem Inf Model; 2010 May; 50(5):906-23. PubMed ID: 20392095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB.
    Badrichani AZ; Stroka DM; Bilbao G; Curiel DT; Bach FH; Ferran C
    J Clin Invest; 1999 Feb; 103(4):543-53. PubMed ID: 10021463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double point mutation at residues Ile14 and Val15 of Bcl-2 uncovers a role for the BH4 domain in both protein stability and function.
    Monaco G; La Rovere R; Karamanou S; Welkenhuyzen K; Ivanova H; Vandermarliere E; Di Martile M; Del Bufalo D; De Smedt H; Parys JB; Economou A; Bultynck G
    FEBS J; 2018 Jan; 285(1):127-145. PubMed ID: 29131545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for involvement of BH3-only proapoptotic members in adenovirus-induced apoptosis.
    Subramanian T; Vijayalingam S; Lomonosova E; Zhao LJ; Chinnadurai G
    J Virol; 2007 Oct; 81(19):10486-95. PubMed ID: 17652400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.
    Rong YP; Barr P; Yee VC; Distelhorst CW
    Biochim Biophys Acta; 2009 Jun; 1793(6):971-8. PubMed ID: 19056433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Bcl-2 proteins Noxa and Bcl-xL co-ordinately regulate oxidative stress-induced apoptosis.
    Eno CO; Zhao G; Olberding KE; Li C
    Biochem J; 2012 May; 444(1):69-78. PubMed ID: 22380599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
    Yang MC; Loh JK; Li YY; Huang WS; Chou CH; Cheng JT; Wang YT; Lieu AS; Howng SL; Hong YR; Chou AK
    Int J Oncol; 2015 Mar; 46(3):1304-16. PubMed ID: 25586056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.
    Trisciuoglio D; De Luca T; Desideri M; Passeri D; Gabellini C; Scarpino S; Liang C; Orlandi A; Del Bufalo D
    Neoplasia; 2013 Mar; 15(3):315-27. PubMed ID: 23479509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
    Schmitt E; Paquet C; Beauchemin M; Bertrand R
    Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probing Gallate-Mediated Selectivity and High-Affinity Binding of Epigallocatechin Gallate: a Way-Forward in the Design of Selective Inhibitors for Anti-apoptotic Bcl-2 Proteins.
    Olotu FA; Agoni C; Adeniji E; Abdullahi M; Soliman ME
    Appl Biochem Biotechnol; 2019 Mar; 187(3):1061-1080. PubMed ID: 30155742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells.
    Aranovich A; Liu Q; Collins T; Geng F; Dixit S; Leber B; Andrews DW
    Mol Cell; 2012 Mar; 45(6):754-63. PubMed ID: 22464442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members.
    Hsu SY; Lin P; Hsueh AJ
    Mol Endocrinol; 1998 Sep; 12(9):1432-40. PubMed ID: 9731710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1.
    Yasuda M; Chinnadurai G
    Oncogene; 2000 May; 19(19):2363-7. PubMed ID: 10822388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boo, a novel negative regulator of cell death, interacts with Apaf-1.
    Song Q; Kuang Y; Dixit VM; Vincenz C
    EMBO J; 1999 Jan; 18(1):167-78. PubMed ID: 9878060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.
    Lebedeva I; Rando R; Ojwang J; Cossum P; Stein CA
    Cancer Res; 2000 Nov; 60(21):6052-60. PubMed ID: 11085527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
    Fiebig AA; Zhu W; Hollerbach C; Leber B; Andrews DW
    BMC Cancer; 2006 Aug; 6():213. PubMed ID: 16928273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bcl-2 family members as molecular targets in cancer therapy.
    Marzo I; Naval J
    Biochem Pharmacol; 2008 Oct; 76(8):939-46. PubMed ID: 18638457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis.
    Zhou F; Yang Y; Xing D
    FEBS J; 2011 Feb; 278(3):403-13. PubMed ID: 21182587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.